BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 25239005)

  • 1. Prognostic significance of lymphovascular invasion in upper urinary tract urothelial carcinoma is influenced by tumor location.
    Lee HY; Li CC; Huang CN; Ke HL; Li WM; Liang PI; Yang SF; Tu HP; Wu WJ; Yeh HC
    Ann Surg Oncol; 2015 Apr; 22(4):1392-400. PubMed ID: 25239005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy.
    Hurel S; Rouprêt M; Ouzzane A; Rozet F; Xylinas E; Zerbib M; Berod AA; Ruffion A; Adam E; Cussenot O; Houlgatte A; Phé V; Nouhaud FX; Bensadoun H; Delage F; Guillotreau J; Guy L; Karsenty G; De La Taille A; Colin P;
    BJU Int; 2013 Jun; 111(8):1199-207. PubMed ID: 23650914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer.
    Akao J; Matsuyama H; Yamamoto Y; Hara T; Kawai Y; Sakano S; Ohmi C; Gondo T; Naito K
    BJU Int; 2008 Aug; 102(5):572-5. PubMed ID: 18485032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
    Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
    BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
    Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ
    Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Miyazaki Y; Kobayashi H; Kaneko G; Hagiwara M; Ide H; Obata J; Hoshino K; Hayakawa N; Kosaka T; Hara S; Oyama M; Momma T; Nakajima Y; Jinzaki M; Oya M
    Ann Surg Oncol; 2014 Nov; 21(12):4041-8. PubMed ID: 24912614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract.
    Hong B; Park S; Hong JH; Kim CS; Ro JY; Ahn H
    Urology; 2005 Apr; 65(4):692-6. PubMed ID: 15833510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between lymphovascular invasion and oncologic outcomes among upper urinary tract urothelial carcinoma patients who underwent radical nephroureterectomy.
    Song SH; Ye CH; Lee S; Hong SK; Byun SS; Lee SE; Oh JJ
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2863-2870. PubMed ID: 31501983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
    Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy.
    Lee KS; Kim KH; Yoon YE; Choi KH; Yang SC; Han WK
    Korean J Urol; 2015 Jan; 56(1):41-7. PubMed ID: 25598935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival.
    Colin P; Ouzzane A; Yates DR; Audenet F; Pignot G; Arvin-Berod A; Merigot de Treigny O; Laurent G; Valeri A; Irani J; Saint F; Gardic S; Gres P; Rozet F; Neuzillet Y; Ruffion A; Rouprêt M
    Ann Surg Oncol; 2012 Oct; 19(11):3613-20. PubMed ID: 22843187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic significance of lymphovascular invasion in upper urinary tract carcinoma: a retrospective monocentric analysis].
    Colin P; Verhasselt-Crinquette M; Ouzzane A; Yakoubi R; Bouchery C; Debrock S; Fantoni JC; Villers A; Leroy X
    Prog Urol; 2010 May; 22(6):331-8. PubMed ID: 22541902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.
    Shibing Y; Turun S; Qiang W; Junhao L; Haichao Y; Shengqiang Q; Ping H; Dehong C
    Urol Oncol; 2015 May; 33(5):204.e9-16. PubMed ID: 25800374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
    Margulis V; Shariat SF; Matin SF; Kamat AM; Zigeuner R; Kikuchi E; Lotan Y; Weizer A; Raman JD; Wood CG;
    Cancer; 2009 Mar; 115(6):1224-33. PubMed ID: 19156917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cN0M0).
    Lin WC; Hu FC; Chung SD; Chueh SC; Pu YS; Huang KH
    J Urol; 2008 Sep; 180(3):879-84; discussion 884-5. PubMed ID: 18635224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.
    Chromecki TF; Cha EK; Fajkovic H; Margulis V; Novara G; Scherr DS; Lotan Y; Raman JD; Kassouf W; Bensalah K; Weizer A; Kikuchi E; Roscigno M; Remzi M; Matsumoto K; Walton TJ; Pycha A; Ficarra V; Karakiewicz PI; Zigeuner R; Pummer K; Shariat SF
    Eur Urol; 2012 Feb; 61(2):245-53. PubMed ID: 21975249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of urothelial carcinoma with divergent differentiation in upper urinary tract after radical nephroureterectomy without metastatic diseases: A retrospective cohort study.
    Qin C; Liang EL; Du ZY; Qiu XY; Tang G; Chen FR; Zhang B; Tian DW; Hu HL; Wu CL
    Medicine (Baltimore); 2017 May; 96(21):e6945. PubMed ID: 28538387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.